S&P 500$7,365.46
-1.44%
2m
DOW 30$51,666.84
-0.09%
2m
NASDAQ 100$29,347.27
-3.29%
2m
Russell 2000$295.32
-0.96%
2m
Russell 1000$401.57
-1.32%
2m
S&P 400$3,767.24
-1.04%
2m
S&P 600$1,738.62
-0.36%
2m

CUE BIOPHARMA (CUE)

NASDAQ

$27.40+$0.50 (+1.86%)

Price as of Jun 23, 2026 6:33 PM EDT

$129.1M
Market Cap
23.97%
1-Year Change
Biotechnology
Industry

Annual

Quarterly

	12/31/2025	12/31/2024	12/31/2023	12/31/2022
Income Statement
Total Operating Revenue	27.5M +195.75%	9.3M +69.16%	5.5M +340.88%	1.2M -91.67%
Cost of Revenue	1.7M -22.73%	2.2M -11.04%	2.5M +15.45%	2.1M -5.18%
Gross Profit	25.8M +263.57%	7.1M +134.90%	3.0M +436.43%	-896,773 -107.07%
Sales and Marketing Expense	N/A N/A	N/A N/A	N/A N/A	N/A N/A
Research and Development Expense	-37.7M +3.99%	-36.3M -11.05%	-40.8M +5.76%	-38.6M -6.70%
Depreciation and Amortization Expense	958,000 +141.31%	397,000 -28.60%	556,000 -39.71%	922,216 -26.67%
Total Operating Expenses	54.0M +6.36%	50.8M -11.89%	57.6M +5.82%	54.5M -7.13%
Operating Profit	-26.6M -36.02%	-41.5M -20.42%	-52.1M -2.02%	-53.2M +21.76%
Interest Income	N/A N/A	N/A N/A	N/A N/A	N/A N/A
Interest Expense	-357,000 -55.15%	-796,000 -36.06%	-1.2M +74.41%	-713,815 N/A
Interest Income and Expense and Net	-357,000 -55.15%	-796,000 -36.06%	-1.2M +74.41%	-713,815 N/A
Total Nonoperating Income and Expense	450,000 -45.52%	826,000 -41.67%	1.4M +560.36%	214,427 +367.18%
Income before Taxes	-26.6M -36.02%	-41.5M -20.42%	-52.1M -1.62%	-53.0M +21.40%
Income Taxes	500,000 N/A	N/A N/A	N/A N/A	0 -100.00%
Extraordinary Items	N/A N/A	N/A N/A	N/A N/A	N/A N/A
Net Income	-26.6M -34.60%	-40.7M -19.83%	-50.7M -4.30%	-53.0M +20.04%
Net Income from Continuing Operations Applicable to Common	-26.6M -34.60%	-40.7M -19.83%	-50.7M -4.30%	-53.0M +21.40%
Basic EPS and Net Income	-0.28 -61.11%	-0.72 -35.14%	-1.11 -25.50%	-1.49 +5.67%
Diluted EPS and Net Income	-0.28 -61.11%	-0.72 -35.14%	-1.11 -25.50%	-1.49 +5.67%
Basic Weighted Average Shares	94.7M +68.18%	56.3M +23.11%	45.8M +28.35%	35.6M +13.95%
Diluted Weighted Average Shares	94.7M +68.18%	56.3M +23.11%	45.8M +28.35%	35.6M +13.95%
Balance Sheet
Cash and Cash Equivalents	27.1M +20.82%	22.5M -53.71%	48.5M -6.01%	51.6M -19.82%
Short-Term Investments	N/A N/A	0 N/A	0 -100.00%	24.7M N/A
Cash and Cash Equivalents and Short-Term Investments	27.1M +20.82%	22.5M -53.71%	48.5M -36.41%	76.3M +18.51%
Total Current Assets	37.0M +47.12%	25.1M -51.14%	51.5M -33.34%	77.2M +12.73%
Accumulated Depreciation	3.7M -0.46%	3.7M +1.77%	3.6M -14.75%	4.2M +23.16%
Property and Plant and Equipment and Net	241,000 -48.83%	471,000 -40.75%	795,000 -46.97%	1.5M -29.01%
Total Long-Term Assets	94,000 -10.48%	105,000 -10.26%	117,000 -8.83%	128,333 -8.33%
Total Assets	42.2M +31.13%	32.2M -47.68%	61.5M -32.59%	91.3M +9.45%
Income Taxes Payable	N/A N/A	N/A N/A	N/A N/A	N/A N/A
Total Short-Term Debt	0 -100.00%	4.3M +9.34%	4.0M +101.88%	2.0M -90.18%
Total Current Liabilities	13.5M -1.42%	13.7M -19.86%	17.1M +47.91%	11.5M -9.69%
Total Long-Term Debt	N/A N/A	0 -100.00%	4.2M -47.70%	8.0M N/A
Total Long-Term Liabilities	2.3M +127.92%	1.0M -86.38%	7.4M -47.60%	14.1M +174.40%
Total Liabilities	15.8M +7.41%	14.7M -39.90%	24.4M -4.51%	25.6M +42.95%
Retained Earnings	-368.5M +7.78%	-341.9M +13.50%	-301.2M +20.26%	-250.5M +26.85%
Total Stockholders Equity	26.4M +51.05%	17.5M -52.81%	37.1M -43.54%	65.7M +0.29%
Total Shares Outstanding	96.6M +56.30%	61.8M +43.62%	43.0M 0.00%	43.0M +33.66%
Cash Flow
Cash from Operating Activities	-21.7M -40.30%	-36.3M -9.09%	-40.0M -4.41%	-41.8M +7.64%
Capital Expenditures	177,000 +168.18%	66,000 N/A	0 -100.00%	170,746 -81.30%
Cash from Investing Activities	75,000 +134.38%	32,000 -99.87%	25.0M +201.59%	-24.6M -370.19%
Dividends Paid	N/A N/A	N/A N/A	N/A N/A	N/A N/A
Cash from Financing Activities	26.3M +156.67%	10.2M -13.63%	11.9M -77.90%	53.7M +178.99%
Financials Ratio
Gross Margin	93.81% +22.93%	76.31% +38.86%	54.95% +176.31%	-72.02% -184.84%
Operating Margin	-96.67% -78.37%	-446.86% -52.96%	-949.89% -77.78%	-4,274.31% +1,361.01%
Return on Assets	-71.51% -17.62%	-86.80% +30.72%	-66.40% +9.40%	-60.69% +25.71%
Return on Equity	-121.11% -18.74%	-149.03% +50.94%	-98.73% +22.16%	-80.82% +32.14%
Revenue Growth	195.75% +183.03%	69.16% -79.71%	340.88% +471.88%	-91.67% -124.53%
Current Ratio	2.74 +49.24%	1.84 -39.04%	3.01 -54.93%	6.68 +24.83%
Cash Ratio	2.01 +22.57%	1.64 -42.23%	2.84 -36.45%	4.47 -11.21%
Debt-to-Equity Ratio	N/A N/A	0.25 +12.44%	0.22 +44.68%	0.15 N/A
Debt-to-Assets Ratio	N/A N/A	0.13 +1.43%	0.13 +21.19%	0.11 N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow